MBR Co.

Ōsaka, Japan
Ōsaka, Japan
SEARCH FILTERS
Time filter
Source Type

News Article | April 26, 2017
Site: www.businesswire.com

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Total Membrane Systems Market, Forecast to 2021" report to their offering. The market size for 2016 is $1.33 billion and is calculated based on the installed base of membranes in the municipal and industrial segments. This study provides an in-depth insight on the European membrane systems market in 2016 covering membrane systems like microfiltration, ultrafiltration, reverse osmosis, and nanofiltration that are used for treating water and wastewater for both municipal and industrial segments, as well as the membrane bioreactor system (MBR) market for both industrial and municipal segment across various regions in Europe. Apart from providing market trends for the type of membranes, it provides data about trends of membrane material, i.e., polymeric and ceramic membranes as well. The study also provides a 5-year forecast of revenue and cumulative installed base with 2016 as the base year. It also includes the latest trends influencing the market and future opportunities for different membranes in the municipal and industrial segments in Europe. The highlight of the study is the information on the cumulative installed base of membranes for water and wastewater treatment industrial and municipal segments. The cumulative installed base will indicate the addressed and addressable markets in regions like UK, Germany, France, Iberia, Italy, Scandinavia, Alpine, and Benelux. For more information about this report visit http://www.researchandmarkets.com/research/cchtcf/european_total


News Article | April 20, 2017
Site: globenewswire.com

Quebec City, April 20, 2017 - (TSXV: HEO) - H O Innovation Inc. ("H O Innovation" or the "Corporation") is proud to announce that it was awarded six (6) new projects in the United States. These new contracts bring the Corporation's project sales backlog to $58.2 M. The Corporation's first contract is a reverse osmosis ("RO") system treating Lake Texoma's water, located on the Texas and Oklahoma border. This new system will replace the existing conventional and electrodialysis reversal (EDR) one previously installed. H O Innovation had also won the contract for the ultrafiltration system using the FiberFlexTM open-platform, for that same municipality, at the end of 2015. By awarding this project to H O Innovation, the customer will be able to save more time and money on the integration of the new RO system within the existing UF one. With this extension, the system will treat 11.3 MGD (42,775 m3/day) of ultrafiltered water and 5 MGD (18,927 m3/day) of reverse osmosis effluent, creating the Corporation's largest combined UF and RO project. The second project awarded to H O Innovation consists of a skid mounted nanofiltration ("NF") system to serve as an expansion to the existing system that the Corporation provided back in 1999. This system will be shipped by boat and will produce 0.4 MGD (1,308 m3/day) of potable water for a municipality located on the North Slope of Alaska. A pair of additional contracts brings H O Innovation to work with two municipalities in the State of Montana. The first is a wastewater facility using the Corporation's new flexMBRTM open-platform membrane bioreactor (MBR). Flat sheet membranes will be used in the process for separation of solids to help meet regulatory requirements. The second municipal project is a FiberFlexTM UF system delivering municipal drinking water. The Corporation has also won two smaller water treatment projects, a reverse osmosis facility in the State of Florida and another FiberFlexTM UF in Michigan. "We are very proud of the wide diversity of technologies used in these new projects that span our core competencies: ultrafiltration, reverse osmosis, nanofiltration and membrane bioreactors. These new flexMBRTM and FiberFlexTM contracts also confirm the Corporation's ability to build on an expanding market trend for flexibility and contractual freedom for membrane asset management", stated Denis Guibert, Vice President and General Manager of Engineering Division of H O Innovation. About H O Innovation H O Innovation designs and provides state-of-the-art, custom-built and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation's activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit www.h2oinnovation.com. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the Alternext Exchange accepts responsibility for the adequacy or accuracy of this release.


News Article | May 4, 2017
Site: www.businesswire.com

LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global industrial water treatment equipment market provides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline. Thanikachalam Chandrasekaran, a lead analyst from Technavio, specializing in research on water and waste management sector, says, “Industry-specific demands and the growth in industrial development will drive the global industrial water treatment equipment market during the forecast period. Water is also a critical element of manufacturing industries like food and beverage, pharmaceutical, and pulp and paper.” Growing production activities in these manufacturing industries will require adherence to stringent environmental regulations and water conservation norms. This will drive water reuse globally, which will have a positive impact on the global industrial water treatment equipment market. Looking for more information on this market? Request a free sample report Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more. The top three emerging trends driving the global industrial water treatment equipment market according to Technavio energy research analysts are: Plenty of water is available on the surface of the earth, and it has been estimated to be sufficient for future generations. However, most of the water on the earth's surface is unsafe to drink or use for basic activities, such as cooking and agriculture, as it contains various contaminants such as factory wastes, pollutants, and oil. “Water purification is gaining importance due to the shrinking water resources worldwide and increasing wastewater disposal costs. In 2014, around 11.12% of the global population lacked access to water globally, and four out of 10 people lacked access to improved sanitation,” according to Thanikachalam. Membrane technologies play a vital role in water and energy sustainability. Some of the membrane technologies such as wastewater treatment by MBR, desalination by RO and membrane-based fuel cells are already applied in industries at scale. Besides addressing energy and water scarcity, membrane technologies meet sustainability criteria regarding environmental impacts, ease of use, land usage, adaptability, and flexibility. However, they still need to be improved regarding affordability and cost, energy consumption, and expertise. To achieve these improvements in water treatment, advances in membrane materials are required. Increased need for water treatment in developing countries The increased need for safe water in developing countries is one of the main reasons for the rise in demand for water treatment equipment globally. Very few people in various developing countries in APAC, Africa, and the Middle East have access to usable water. More than 1 billion people in various developing countries do not have access to usable water. Also, many developing countries such as China and India face difficulties in treating water and discharging wastewater safely, which is leading to the scarcity of usable water. The increased need for water treatment in developing countries is one of the key trends expected to drive the growth of the market. The key vendors are as follows: Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like power, energy storage, and oil and gas. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently. Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies. Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users. If you are interested in more information, please contact our media team at media@technavio.com.


News Article | April 20, 2017
Site: globenewswire.com

Quebec City, April 20, 2017 - (TSXV: HEO) - H O Innovation Inc. ("H O Innovation" or the "Corporation") is proud to announce that it was awarded six (6) new projects in the United States. These new contracts bring the Corporation's project sales backlog to $58.2 M. The Corporation's first contract is a reverse osmosis ("RO") system treating Lake Texoma's water, located on the Texas and Oklahoma border. This new system will replace the existing conventional and electrodialysis reversal (EDR) one previously installed. H O Innovation had also won the contract for the ultrafiltration system using the FiberFlexTM open-platform, for that same municipality, at the end of 2015. By awarding this project to H O Innovation, the customer will be able to save more time and money on the integration of the new RO system within the existing UF one. With this extension, the system will treat 11.3 MGD (42,775 m3/day) of ultrafiltered water and 5 MGD (18,927 m3/day) of reverse osmosis effluent, creating the Corporation's largest combined UF and RO project. The second project awarded to H O Innovation consists of a skid mounted nanofiltration ("NF") system to serve as an expansion to the existing system that the Corporation provided back in 1999. This system will be shipped by boat and will produce 0.4 MGD (1,308 m3/day) of potable water for a municipality located on the North Slope of Alaska. A pair of additional contracts brings H O Innovation to work with two municipalities in the State of Montana. The first is a wastewater facility using the Corporation's new flexMBRTM open-platform membrane bioreactor (MBR). Flat sheet membranes will be used in the process for separation of solids to help meet regulatory requirements. The second municipal project is a FiberFlexTM UF system delivering municipal drinking water. The Corporation has also won two smaller water treatment projects, a reverse osmosis facility in the State of Florida and another FiberFlexTM UF in Michigan. "We are very proud of the wide diversity of technologies used in these new projects that span our core competencies: ultrafiltration, reverse osmosis, nanofiltration and membrane bioreactors. These new flexMBRTM and FiberFlexTM contracts also confirm the Corporation's ability to build on an expanding market trend for flexibility and contractual freedom for membrane asset management", stated Denis Guibert, Vice President and General Manager of Engineering Division of H O Innovation. About H O Innovation H O Innovation designs and provides state-of-the-art, custom-built and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation's activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit www.h2oinnovation.com. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the Alternext Exchange accepts responsibility for the adequacy or accuracy of this release.


News Article | April 20, 2017
Site: globenewswire.com

Quebec City, April 20, 2017 - (TSXV: HEO) - H O Innovation Inc. ("H O Innovation" or the "Corporation") is proud to announce that it was awarded six (6) new projects in the United States. These new contracts bring the Corporation's project sales backlog to $58.2 M. The Corporation's first contract is a reverse osmosis ("RO") system treating Lake Texoma's water, located on the Texas and Oklahoma border. This new system will replace the existing conventional and electrodialysis reversal (EDR) one previously installed. H O Innovation had also won the contract for the ultrafiltration system using the FiberFlexTM open-platform, for that same municipality, at the end of 2015. By awarding this project to H O Innovation, the customer will be able to save more time and money on the integration of the new RO system within the existing UF one. With this extension, the system will treat 11.3 MGD (42,775 m3/day) of ultrafiltered water and 5 MGD (18,927 m3/day) of reverse osmosis effluent, creating the Corporation's largest combined UF and RO project. The second project awarded to H O Innovation consists of a skid mounted nanofiltration ("NF") system to serve as an expansion to the existing system that the Corporation provided back in 1999. This system will be shipped by boat and will produce 0.4 MGD (1,308 m3/day) of potable water for a municipality located on the North Slope of Alaska. A pair of additional contracts brings H O Innovation to work with two municipalities in the State of Montana. The first is a wastewater facility using the Corporation's new flexMBRTM open-platform membrane bioreactor (MBR). Flat sheet membranes will be used in the process for separation of solids to help meet regulatory requirements. The second municipal project is a FiberFlexTM UF system delivering municipal drinking water. The Corporation has also won two smaller water treatment projects, a reverse osmosis facility in the State of Florida and another FiberFlexTM UF in Michigan. "We are very proud of the wide diversity of technologies used in these new projects that span our core competencies: ultrafiltration, reverse osmosis, nanofiltration and membrane bioreactors. These new flexMBRTM and FiberFlexTM contracts also confirm the Corporation's ability to build on an expanding market trend for flexibility and contractual freedom for membrane asset management", stated Denis Guibert, Vice President and General Manager of Engineering Division of H O Innovation. About H O Innovation H O Innovation designs and provides state-of-the-art, custom-built and integrated water treatment solutions based on membrane filtration technology for municipal, industrial, energy and natural resources end-users. The Corporation's activities rely on three pillars which are i) water and wastewater projects; ii) specialty products and services, including a complete line of specialty chemicals, consumables, specialized products for the water treatment industry as well as control and monitoring systems; and iii) operation and maintenance services for water and wastewater treatment systems. For more information, visit www.h2oinnovation.com. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the Alternext Exchange accepts responsibility for the adequacy or accuracy of this release.


News Article | May 15, 2017
Site: marketersmedia.com

LONDON, UK / ACCESSWIRE / May 15, 2017 / Active Wall St. announces its post-earnings coverage on Aetna Inc. (NYSE: AET). The Company released its first quarter fiscal 2017 results on May 02, 2017. The health care Company exceeded earnings estimates. Register with us now for your free membership at: One of Aetna's competitors within the Health Care Plans space, Magellan Health, Inc. (NASDAQ: MGLN), reported on April 26, 2017, its financial results for Q1 ended March 31, 2017. AWS will be initiating a research report on Magellan Health in the coming days. Today, AWS is promoting its earnings coverage on AET; touching on MGLN. Get our free coverage by signing up to: Aetna's total revenue and adjusted revenue for the quarter ended March 31, 2017, were $15.17 billion and $15.49 billion, respectively, and both approximately $15.69 billion, each, for Q1 2016. The decline in total revenue and adjusted revenue was primarily due to lower premiums in Aetna's Health Care segment, including lower membership in Aetna's ACA compliant individual and small group products and the temporary suspension of the HIF in 2017. The Company's total revenue numbers came in below analysts' consensus of $15.40 billion. For Q1 2017, Aetna's total company expense ratio was 25.4% compared to 18.2% for Q1 2016, primarily due to costs associated with the termination during the reported quarter of the Humana Merger's Agreement. The Company's adjusted expense ratio was 16.0% for Q1 2017 and 18.0% for Q1 2016, respectively. For Q1 2017, Aetna's net loss was $381 million compared with net income of $737 million for Q1 2016. The net loss during the reported quarter reflected costs associated with the termination of the Humana Merger Agreement. The Company's adjusted earnings were $939 million, or $2.71 per share, for Q1 2017 compared with $821 million or $2.32 per share for Q1 2016. Aetna's adjusted EPS surpassed Wall Street's estimates of $2.37 per share. During Q1 2017, Aetna's Health Care segment which provides a full range of insured and self-insured medical, pharmacy, dental, and behavioural health products and services, reported total revenue and adjusted revenue of both $14.8 billion and both $15.0 billion for Q1 2016. The decrease in total revenue and adjusted revenue was primarily due to lower membership in Aetna's ACA compliant individual and small group products and the temporary suspension of the HIF in 2017. During Q1 2017, Aetna's medical membership decreased by 664 thousand compared with December 31, 2016, primarily reflecting declines in Aetna's commercial insured products primarily related to Aetna's ACA compliant individual and small group products. For Q1 2017, the Company's Commercial Medical benefit ratios (MBR) increased 1.6 pts on a y-o-y basis to 79.4% primarily due to the temporary suspension of the HIF in 2017 and higher medical costs in Aetna's individual Commercial products, including a $110 million premium deficiency reserve. The increase was partially offset by improved performance in Aetna's group Commercial Insured products. Aetna's Q1 2017 government MBR increased to 85.3% compared with Q1 2016 MBR of 83.4%. Aetna's days claims payable was 53 days at March 31, 2017, a decrease of four days compared with March 31, 2016. The y-o-y drop was driven by a number of factors, including the operational maturation of new Medicaid contracts, decreased claims processing times, and business mix primarily related to the decline in Aetna's individual Commercial product membership. For Q1 2017, Aetna's healthcare segment reported income before income taxes of $1.2 billion compared with $1.4 billion for Q1 2016. The decrease in income before income taxes was primarily due to the reported quarter reflecting a $231 million pre-tax expense related to estimated future guaranty fund assessments. The segment's pre-tax adjusted earnings remained relatively flat at approximately $1.5 billion, despite the negative impact of the temporary suspension of the HIF in 2017. Aetna's Group Insurance segment, which includes group life, disability and long-term care products, reported total revenue of $621 million and $612 million for Q1 2017 and Q1 2016, respectively. The segment's adjusted revenue was $619 million and $609 million for the reported quarter and for the year earlier same quarter, respectively. Total revenue and adjusted revenue increased primarily due to higher premiums in Aetna's life and disability products and higher net investment income. For Q1 2017, the Group Insurance segment reported income before income taxes of $35 million compared with $28 million for Q1 2016. The segment's pre-tax adjusted earnings were $33 million for the reported quarter compared with $25 million for the prior year's comparable quarter. For Q1 2017, Aetna's Large Case Pensions segment, which manages a variety of discontinued and other retirement and savings products, primarily for qualified pension plans, reported total revenue of $86 million compared to revenue of $67 million for Q1 2016. The segment's adjusted revenue was $86 million for the reported quarter and $65 million for the year earlier quarter. Total revenue and adjusted revenue increased primarily due to higher net investment income. Large Case Pensions segment's income before income taxes totaled $4 million for Q1 2017 compared with $3 million for Q1 2016. Pre-tax adjusted earnings were $4 million for the reported quarter compared with $1 million for the year earlier same quarter. Aetna's total debt to consolidated capitalization ratio was 39.8% at March 31, 2017, compared with 53.6% at December 31, 2016. The total debt to consolidated capitalization ratio at the end of Q1 2017 reflects the redemption of $10.2 billion aggregate principal amount of the senior notes issued in 2016, $750 million aggregate principal number of senior notes due in 2020 and the repayment at maturity of $383 million aggregate principal number of senior notes, each, during the reported quarter. On Friday, May 12, 2017, the stock closed the trading session at $142.90, falling 1.03% from its previous closing price of $144.39. A total volume of 2.45 million shares have exchanged hands. Aetna's stock price advanced 10.71% in the last month, 17.89% in the past three months, and 21.80% in the previous six months. Furthermore, since the start of the year, shares of the Company have gained 15.92%. The stock is trading at a PE ratio of 44.35 and has a dividend yield of 1.40%. Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. AWS has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/. For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. LONDON, UK / ACCESSWIRE / May 15, 2017 / Active Wall St. announces its post-earnings coverage on Aetna Inc. (NYSE: AET). The Company released its first quarter fiscal 2017 results on May 02, 2017. The health care Company exceeded earnings estimates. Register with us now for your free membership at: One of Aetna's competitors within the Health Care Plans space, Magellan Health, Inc. (NASDAQ: MGLN), reported on April 26, 2017, its financial results for Q1 ended March 31, 2017. AWS will be initiating a research report on Magellan Health in the coming days. Today, AWS is promoting its earnings coverage on AET; touching on MGLN. Get our free coverage by signing up to: Aetna's total revenue and adjusted revenue for the quarter ended March 31, 2017, were $15.17 billion and $15.49 billion, respectively, and both approximately $15.69 billion, each, for Q1 2016. The decline in total revenue and adjusted revenue was primarily due to lower premiums in Aetna's Health Care segment, including lower membership in Aetna's ACA compliant individual and small group products and the temporary suspension of the HIF in 2017. The Company's total revenue numbers came in below analysts' consensus of $15.40 billion. For Q1 2017, Aetna's total company expense ratio was 25.4% compared to 18.2% for Q1 2016, primarily due to costs associated with the termination during the reported quarter of the Humana Merger's Agreement. The Company's adjusted expense ratio was 16.0% for Q1 2017 and 18.0% for Q1 2016, respectively. For Q1 2017, Aetna's net loss was $381 million compared with net income of $737 million for Q1 2016. The net loss during the reported quarter reflected costs associated with the termination of the Humana Merger Agreement. The Company's adjusted earnings were $939 million, or $2.71 per share, for Q1 2017 compared with $821 million or $2.32 per share for Q1 2016. Aetna's adjusted EPS surpassed Wall Street's estimates of $2.37 per share. During Q1 2017, Aetna's Health Care segment which provides a full range of insured and self-insured medical, pharmacy, dental, and behavioural health products and services, reported total revenue and adjusted revenue of both $14.8 billion and both $15.0 billion for Q1 2016. The decrease in total revenue and adjusted revenue was primarily due to lower membership in Aetna's ACA compliant individual and small group products and the temporary suspension of the HIF in 2017. During Q1 2017, Aetna's medical membership decreased by 664 thousand compared with December 31, 2016, primarily reflecting declines in Aetna's commercial insured products primarily related to Aetna's ACA compliant individual and small group products. For Q1 2017, the Company's Commercial Medical benefit ratios (MBR) increased 1.6 pts on a y-o-y basis to 79.4% primarily due to the temporary suspension of the HIF in 2017 and higher medical costs in Aetna's individual Commercial products, including a $110 million premium deficiency reserve. The increase was partially offset by improved performance in Aetna's group Commercial Insured products. Aetna's Q1 2017 government MBR increased to 85.3% compared with Q1 2016 MBR of 83.4%. Aetna's days claims payable was 53 days at March 31, 2017, a decrease of four days compared with March 31, 2016. The y-o-y drop was driven by a number of factors, including the operational maturation of new Medicaid contracts, decreased claims processing times, and business mix primarily related to the decline in Aetna's individual Commercial product membership. For Q1 2017, Aetna's healthcare segment reported income before income taxes of $1.2 billion compared with $1.4 billion for Q1 2016. The decrease in income before income taxes was primarily due to the reported quarter reflecting a $231 million pre-tax expense related to estimated future guaranty fund assessments. The segment's pre-tax adjusted earnings remained relatively flat at approximately $1.5 billion, despite the negative impact of the temporary suspension of the HIF in 2017. Aetna's Group Insurance segment, which includes group life, disability and long-term care products, reported total revenue of $621 million and $612 million for Q1 2017 and Q1 2016, respectively. The segment's adjusted revenue was $619 million and $609 million for the reported quarter and for the year earlier same quarter, respectively. Total revenue and adjusted revenue increased primarily due to higher premiums in Aetna's life and disability products and higher net investment income. For Q1 2017, the Group Insurance segment reported income before income taxes of $35 million compared with $28 million for Q1 2016. The segment's pre-tax adjusted earnings were $33 million for the reported quarter compared with $25 million for the prior year's comparable quarter. For Q1 2017, Aetna's Large Case Pensions segment, which manages a variety of discontinued and other retirement and savings products, primarily for qualified pension plans, reported total revenue of $86 million compared to revenue of $67 million for Q1 2016. The segment's adjusted revenue was $86 million for the reported quarter and $65 million for the year earlier quarter. Total revenue and adjusted revenue increased primarily due to higher net investment income. Large Case Pensions segment's income before income taxes totaled $4 million for Q1 2017 compared with $3 million for Q1 2016. Pre-tax adjusted earnings were $4 million for the reported quarter compared with $1 million for the year earlier same quarter. Aetna's total debt to consolidated capitalization ratio was 39.8% at March 31, 2017, compared with 53.6% at December 31, 2016. The total debt to consolidated capitalization ratio at the end of Q1 2017 reflects the redemption of $10.2 billion aggregate principal amount of the senior notes issued in 2016, $750 million aggregate principal number of senior notes due in 2020 and the repayment at maturity of $383 million aggregate principal number of senior notes, each, during the reported quarter. On Friday, May 12, 2017, the stock closed the trading session at $142.90, falling 1.03% from its previous closing price of $144.39. A total volume of 2.45 million shares have exchanged hands. Aetna's stock price advanced 10.71% in the last month, 17.89% in the past three months, and 21.80% in the previous six months. Furthermore, since the start of the year, shares of the Company have gained 15.92%. The stock is trading at a PE ratio of 44.35 and has a dividend yield of 1.40%. Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. AWS has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/. For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


News Article | May 8, 2017
Site: www.techrepublic.com

With the release of the Windows 10 Creators Update, Microsoft continues to make good on its promise to provide steady, yearly updates to keep improving the OS over its lifetime. This third feature update, dubbed Build 1703, brings with it an assortment of end-user enhancements intended to help users push the boundaries of what their Windows 10 computer can do. While the focus has remained largely on the end-user impact, enterprise users and IT personnel have more than their share of improvements that add new features and revitalize existing ones. Let's have a look at the 10 best features contained in Creators Update. Taking a page out of Group Policy Management Console (GPMC), Microsoft has enhanced its MDM support by allowing security policies that were previously available only to GPMC to be applied natively via MDM. This includes configuration service providers (CSPs) ,which extend management to a number of configuration settings controlling hardware, software, deployment, and application virtualization. The Windows Registry has gained an address bar feature to better search for specific keys and entries. It also has picked up keyboard shortcuts and the ability to recognize abbreviations for commonly used data fields to simplify the process of managing the registry. In an effort to bridge the gap between Windows and Linux distributions, Microsoft has designed the WSL to allow the use of Linux command-line tools natively on Windows 10. No virtualization required. Built on top of Windows Information Protection (WIP), MAM is used to effectively manage access to a company's data and security on personally owned devices. When enabled, enforcement of WIP policies is limited to WIP-aware applications, as well as, those applications which are "enlightened", and can discern corporate data from personal data to apply its policies to safely protect corporate data without handling personal data. Used in the provisioning of packages for a number of Windows-based devices, Windows Imaging and Configuration Designer, as it was formerly named, was available as part of the Windows Assessment and Deployment Kit (ADK). Now called Windows Configuration Designer, it's available as an app in the Windows Store. It retains its feature set and gains several abilities. Not only can it configure devices offline, but it can also do so through a number of means, such as NFC tags, USB flash drives, and barcodes. Though not a tool that will be immediately utilized by organizations, those with the existing equipment in place will welcome this new command-line tool that enables Master Boot Record (MBR) disk conversion to the more modern GUID Partition Table (GPT) format, which is a requirement when using UEFI instead of the older, less secure BIOS. Drawing upon its success with Windows Hello in the consumer space, as well as accommodating Azure AD users, Microsoft has developed its authentication scheme for Creators Update to include enhanced facial recognition, dynamic locking of a device when the user is away, and two-factor authentication for improved security. MMAT is a new Microsoft application aimed at providing administrators guidance on transitioning Windows 10 device management from Group Policy to MDM. The tool assesses which policies are being applied and whether they are currently available (or have a similar component) within MDM for ease of manageability. The Creators Update includes new policies to manage Start Menu and Taskbar layouts, including restricting access to pages within the Settings app by hiding the pages from end users. Additional policies are geared toward managing support for Microsoft Edge by customizing various security and privacy settings in addition to the overall experience. Beginning with a name change to Windows Defender Antivirus, Windows 10's built-in malware protection now sports the capability to set the level of protection, along with Block At First Sight—Microsoft's answer to protecting against new strains of malware that may as of yet be undetected, based on a file's suspicious activity and by comparing it to automated analysis with its cloud protection back end. What are your impressions of the Windows 10 Creators Update so far? Share your experiences and opinions with fellow TechRepublic members.


News Article | May 9, 2017
Site: www.prweb.com

For 30 years, the Rainforest Alliance has been a global leader in the conservation of forests and natural resources while advancing sustainable livelihoods. Such success can only be accomplished through strategic partnerships with players along every link in the supply chain, from producers to large multinational companies. The Rainforest Alliance is pleased to recognize businesses and individuals committed to protecting the environment, implementing climate solutions, and supporting communities across the globe. Awards will be presented to honorees on May 10th in New York City, at the Rainforest Alliance’s 30th Anniversary Gala Celebration at the American Museum of Natural History. “To come as far as the Rainforest Alliance has in 30 years, we needed the strength of partnership,” said Nigel Sizer, President of the Rainforest Alliance. “Today, we recognize individuals and companies who are addressing some of the most significant challenges humanity has ever faced. These champions are working with us to protect forests and support farmers and communities across the world, affecting real change.” During the day on May 10, honorees and co-chairs will join CEOs, business and thought leaders, and Rainforest Alliance experts at the annual Leadership Summit to discuss strategies for implementing global sustainability and climate goals. Following the summit, participants will gather in the evening for an awards dinner, entertainment, and a silent auction. The gala is co-chaired by long-term Rainforest Alliance friends and supporters Maggie Lear, Tessie Nedelman, Laura Ross, and Cathy Taub, and sponsored by Domtar. Gala proceeds benefit the Rainforest Alliance’s international work in sustainable agriculture, forestry, tourism, human rights, and climate change. The Rainforest Alliance recognizes Felisa Navas Pérez, a three-term president of Asociación Forestal Integral Cruce a La Colorada (AFICC), a forestry concession in the Maya Biosphere Reserve (MBR) in the Petén region of Guatemala. Navas assumed her leadership role shortly after the concession’s board president was murdered, presumably by drug traffickers who want to control local lands so they may clear forest for livestock operations (which in turn serve to launder money). While nearby concessions have collapsed, AFICC has remained solvent and certified under Navas’s leadership. Corporate Sustainability Champions award recognizes companies who have demonstrated an exceptional commitment to sustainability, improving livelihoods, and conserving forests all around the world. Allegro Coffee Company AMResorts Barry Callebaut AG Beef Passion Bettys & Taylors of Harrogate Blommer Chocolate Company Caribou Coffee C.F. Martin & Co., Inc. Chiquita Clearwater Paper Company Clif Bar CMPC Columbia Forest Products Domtar ECOM / Atlantic (USA) Fibria Kenya Tea Development Agency Lavazza Mars, Incorporated Nestlé Nespresso SA Olam International Ltd. Suzano Pulp and Paper Tesco Unilever People and Planet Champions award recognizes the visionary individuals, foundations, partner organizations, and government entities who have helped the Rainforest Alliance advance its mission to build strong forests and healthy communities. Kim Bendheim John Caulkins Citi Foundation Daniel Cohen (In Memoriam) The Colombian Coffee Growers Federation Comisión Nacional Forestal de México Henry Davison The Ford Foundation Forest Stewardship Council Dr. Karl Fossum (In Memoriam) Global Environment Facility Inter-American Development Bank Elysabeth Kleinhans Dr. Thomas E. Lovejoy Millennium Challenge Corporation The Milton and Tamar Maltz Family Foundation Mitsubishi Corporation Foundation for the Americas Jeffrey & Tessie Nedelman Ellen Petersen Robert W. Wilson Charitable Trust Secretaría de Medio Ambiente y Recursos Naturales Secretaría de Turismo de México Sustainable Agriculture Network (SAN) The Sustainable Trade Initiative (IDH) United Nations Environment Programme (UNEP) Alan Wilzig Ann Ziff The Sustainable Development Champions award recognizes the extraordinary achievements of a group of individuals and institutions working alongside local and indigenous communities in Guatemala’s Petén region to promote the economic, environmental, and social health of the Maya Biosphere Reserve and its communities. Asociación de Comunidades Forestales de Petén Continental Floral Greens Defensores de la Naturaleza General Wood Craft Guatemala Ministry of Environment Guatemalan Association of Exporters (AGEXPORT) National Council of Protected Areas North American Wood Products United States Agency for International Development (USAID) University of Minnesota Maggie Lear, Tessie Nedelman, Laura Ross, and Cathy Taub are enormous fans of the Rainforest Alliance and proud Co-Chairs of tonight’s Gala. While traveling to Peru, Ecuador, and Mexico with Rainforest Alliance Executive Vice President Ana Paula Tavares, they witnessed the important work of the Rainforest Alliance firsthand. These visits provided them with opportunities to meet the knowledgeable farmers, foresters, eco-tourism professionals and Rainforest Alliance’s field experts, who are helping to conserve our planet for their children and future generations.


The object is to provide a stable SM-108 derivative, which is effective as a carcinostatic agent, particularly an SM-108 derivative having good storage stability. An SM-108 compound having good storage stability can be produced by producing an organic sulfonic acid salt compound of SM-108. Further, a crystalline SM-108 compound containing a trace amount of an organic carboxylic acid can be produced by using an aqueous solution of the organic sulfonic acid salt of SM-108, and by adding an alkali metal salt of an organic carboxylic acid to the aqueous solution to neutralize the aqueous solution and then causing the crystal precipitation in the solution.


Trademark
Mbr Llc | Date: 2014-02-04

Organic body and beauty care cosmetics, namely, lipstick, lip gloss, blush, eye shadow, foundation, tinted moisturizer, concealer, cosmetic preparations for lightening the skin, eyeliner, bronzer, lotions, creams, serums, non-medicated anti-aging creams for topical use.

Loading MBR Co. collaborators
Loading MBR Co. collaborators